Find Suppliers (API/FDF)
Services
Excipients
Developments
News
Blog
Market Place
Login
Market Place

Narazaciclib

Synopsis, Chemistry

Synopsis
Chemistry

DEVELOPMENTS

7 Drug(s) in Development

7 Drug(s) in Development

DIGITAL CONTENT

10 News

10 News

Synopsis Chemistry

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

EU WC

Listed Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

Drugs in Development News

News

Full Screen View

HanxBio Narazaciclib AML Preclinical Study Published

https://www.prnewswire.com/news-releases/hanxbio-announces-the-publication-of-a-research-paper-in-scientific-reports-on-preclinical-evaluation-of-narazaciclib-for-the-treatment-of-acute-myeloid-leukemia-aml-302124216.html

PR NEWSWIRE

23 Apr 2024

Onconova Therapeutics Narazaciclib Highlights Activity in Mantle Cell Lymphoma

https://www.globenewswire.com//news-release/2023/12/12/2794697/0/en/Onconova-Therapeutics-Narazaciclib-ASH-Poster-Highlights-Activity-in-Treatment-Resistant-Mantle-Cell-Lymphoma.html

GLOBENEWSWIRE

12 Dec 2023

Onconova's Narazaciclib Data Highlights Anti-Tumor Activity v. Other CDK4/6i™s

https://www.globenewswire.com//news-release/2023/12/08/2793371/0/en/Onconova-Therapeutics-Preclinical-Narazaciclib-Data-at-SABCS-Highlights-Differentiated-Anti-Tumor-Activity-v-Other-CDK4-6i-s.html

GLOBENEWSWIRE

08 Dec 2023

Onconova Presents Data on Narazaciclib at the 17th International Conference

https://www.globenewswire.com/news-release/2023/06/14/2688014/0/en/Onconova-Therapeutics-Presents-Preclinical-Data-on-Narazaciclib-at-the-17th-International-Conference-on-Malignant-Lymphoma.html

GLOBENEWSWIRE

14 Jun 2023

Onconova to Participate in R&D Showcase on Narazaciclib in Endometrial Cancer

https://www.globenewswire.com/news-release/2023/05/12/2667736/0/en/Onconova-Therapeutics-to-Participate-in-Ladenburg-Thalmann-Virtual-R-D-Showcase-on-Narazaciclib-in-Endometrial-Cancer.html

GLOBENEWSWIRE

12 May 2023

Onconova doses first patient in trial of endometrial cancer combo therapy

https://www.clinicaltrialsarena.com/news/onconova-patient-cancer-combo/

CLINICAL TRIALS ARENA

12 May 2023

Onconova Doses First Patient in Phase 1/2a Trial of Narazaciclib with Letrozole

https://www.globenewswire.com/news-release/2023/05/11/2666685/0/en/Onconova-Therapeutics-Doses-First-Patient-in-Phase-1-2a-Trial-of-Narazaciclib-Combined-with-Letrozole-in-Endometrial-Cancer.html

GLOBENEWSWIRE

11 May 2023

Onconova Announces the Presentation of New Preclinical Data on Narazaciclib

https://www.globenewswire.com/news-release/2023/04/19/2650128/0/en/Onconova-Therapeutics-Announces-the-Presentation-of-New-Preclinical-Data-on-Narazaciclib-at-the-AACR-Annual-Meeting.html

GLOBENEWSWIRE

19 Apr 2023

Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib

https://www.globenewswire.com/news-release/2022/11/14/2555467/0/en/Onconova-Therapeutics-Announces-Plans-for-a-Phase-1-2a-Trial-of-Narazaciclib-Combined-with-Letrozole-in-Endometrial-Cancer-Reports-Third-Quarter-2022-Financial-Results-and-Provides.html

GLOBENEWSWIRE

14 Nov 2022

Onconova Announces Abstract at ASCO 2022 Highlighting Narazaciclib activity

https://www.globenewswire.com/news-release/2022/05/26/2451675/0/en/Onconova-Therapeutics-Announces-Abstract-at-the-ASCO-Annual-Meeting-Highlighting-Narazaciclib-s-Differentiated-Inhibitory-and-Improved-Safety-Profile-in-Preclinical-Models.html

GLOBENEWSWIRE

26 May 2022